Progress in research frequently awaits the application of new techniques developed in unrelated fields. The biochemistry of the thyroid gland is a particularly good example, for remarkable advances have followed the introduction of paper chromatography and autoradiography with radioactive iodine (131I).
Classical methods had previously shown that the circulating form of thyroid hormone was the free amino-acid thyroxine, and that this compound was produced in the gland by a series of processes substantially as suggested by Harington and Barger (1927) . A number of investigators, however, found that the metabolic activities of thyroid extracts could not be correlated with their thyroxine contents, an anomaly for which recent work has provided a probable explanation.
Discovery of Triiodothyronine
Paper chromatographic studies of butanol extracts of thyroid tissue and plasma of rats previously treated with 131I, showed the presence of hitherto unsuspected iodine-containing compounds, the principal one of which was provisionally designated 'Compound No. -.' This substance was subsequently found in the tissues of intact and thyroidectomized mice after the injection of l3lI-labelled thyroxine (Gross and Leblond, I951), and also in the plasma of patients treated with therapeutic doses of 131I (Gross and Pitt-Rivers, I951).
Rapid progress followed when Gross and PittRivers (I952a) identified this unknown compound as 3:5:3'-triiodothyronine (Fig. i) , the isolation and synthesis of which were simultaneously reported by Roche, Lissitzky and Michel (I952a, b) . The importance of this discovery became evident when the high physiological activity of triiodothyronine was established. When tested by a variety of methods, triiodothyronine proved to be about five times as active as thyroxine, an observation which prompted to suggest that the new compound might be the active form of thyroid hormone and thyroxine its precursor. This theory will be discussed later.
Clinical trials confirmed the high activity of triiodothyronine and it was successfully used in the treatment of myxoedema (Gross, Pitt-Rivers and Trotter, 1952) . Rawson (1952) who found that the anti-thyroxine compound, butyl 4-hydroxy-3:5-diiodobenzoate (BHDB) (Fig. i) , enhanced the action of triiodothyronine in raising the oxygen consumption of mice. This observation was explained on the assumption that BHDB interfered with deiodination processes, thus inhibiting the action of thyroxine by preventing its conversion into the active form, triiodothyronine.
If further deiodination of the latter into inactive compounds were also inhibited by BHDB, the augmentation of its metabolic effects would follow. The observation by Barker, Dirks, Garlick and Klitgaard (1951) (Roche, Michel, Jouan and Wolf, 1955; Albright, Larson, Tomita and Lardy, 1956 ).
Clinical trials showed that triac was of value in the treatment of myxoedema. Lerman and PittRivers (I955, 1956) 
Conclusion
In such a rapidly expanding field, the writer finds it difficult to draw definite conclusions which are not liable to be exploded by new discoveries, but certain general comments may be permitted. It seems fairly certain from its latent period, studies of antithyroxine compounds, its high plasma level in hepatitis and its inactivity in certain hypometabolic patients, that thyroxine requires conversion into some other form before it becomes active. The nature of the active form is a matter for speculation, but it is probable that triiodothyronine is a step in the process because of its high overall activity. This substance is unlikely to be the end-product for it too has a latent period which, however, seems to be shorter than that of thyroxine. The compounds triac and tetrac, which appear to produce immediate effects at least in some tests, may well be the active forms of the hormone.
On the other hand Barker (I956) has suggested that the physiological activity of the thyroid hormones may be the resultant of a whole spectrum of compounds, and it may be quite futile to attempt to characterize any one substance as the active form.
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